OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
1
Result
Show all
Save search
Copy query
Show results for
Proteomics
(1)
Organisms
Homo sapiens
(1)
Repository
pride
(1)
Tissue
Cell culture
(1)
Epithelial cell
(1)
Disease
Malignant neoplasm of ovary
(1)
Technology Type
Bottom-up proteomics
(1)
Mass Spectrometry
(1)
Publication Date
2025
(1)
Lab affiliation
Department of Oncology; Department of Molecular Pharmacology and Experimental Therapeutics; Mayo Clinic, Rochester, Minnesota 55901, USA
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Quantitative phospho- and total proteomics of OVCAR-8 cells treated with brigatinib
This study investigates the effect of 2.5 uM brigatinib on total and phosphorylated protein levels in human high-grade serous OVCAR-8 cells following 1 and 24 hours of treatment.
ORGANISM(S):
Homo sapiens (Human)
2025-12-03
|
PXD070320
|
Pride
Lc-msms
Tmt
Quantitative
Ovcar-8
Brigatinib
Phosphoproteomics
Alk inhibitor
Ovarian cancer
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
